ID: ALA5286047

Max Phase: Preclinical

Molecular Formula: C22H27N3O

Molecular Weight: 349.48

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1CO[C@H]1CCCN(Cc2ccc3c(cnn3C)c2)C1

Standard InChI:  InChI=1S/C22H27N3O/c1-17-6-3-4-7-19(17)16-26-21-8-5-11-25(15-21)14-18-9-10-22-20(12-18)13-23-24(22)2/h3-4,6-7,9-10,12-13,21H,5,8,11,14-16H2,1-2H3/t21-/m0/s1

Standard InChI Key:  LQPXVZLXNDSSPM-NRFANRHFSA-N

Associated Targets(Human)

Sigma opioid receptor 6358 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D4 receptor 7907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma intracellular receptor 2 973 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D1 receptor 9720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.48Molecular Weight (Monoisotopic): 349.2154AlogP: 4.06#Rotatable Bonds: 5
Polar Surface Area: 30.29Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.47CX LogP: 4.02CX LogD: 2.92
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -1.51

References

1. Tolentino KT, Mashinson V, Sharma MK, Chhonker YS, Murry DJ, Hopkins CR..  (2022)  From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.,  244  [PMID:36283180] [10.1016/j.ejmech.2022.114840]

Source